Shared more. Cited more. Safe forever.
    • advanced search
    • submit works
    • about
    • help
    • contact us
    • login
    View Item 
    •   MOspace Home
    • University of Missouri-Columbia
    • Office of Undergraduate Research (MU)
    • Undergraduate Research and Creative Achievements Forum (MU)
    • 2004 Undergraduate Research and Creative Achievements Forum (MU)
    • View Item
    •   MOspace Home
    • University of Missouri-Columbia
    • Office of Undergraduate Research (MU)
    • Undergraduate Research and Creative Achievements Forum (MU)
    • 2004 Undergraduate Research and Creative Achievements Forum (MU)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    advanced searchsubmit worksabouthelpcontact us

    Browse

    All of MOspaceCommunities & CollectionsDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis SemesterThis CollectionDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis Semester

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular AuthorsStatistics by Referrer

    Radioactive materials: Winning the battle against cancer [abstract]

    Lane, Stephanie R., 1982-
    View/Open
    [PDF] Radioactive materials Winning the battle against cancer.pdf (24.97Kb)
    Date
    2004
    Contributor
    University of Missouri-Columbia. Office of Undergraduate Research
    Format
    Abstract
    Metadata
    [+] Show full item record
    Abstract
    Radiopharmaceuticals are drugs containing a radioactive atom that can be used for the treatment of certain cancers. The radiopharmaceuticals we are interested in consist of a radioactive source contained in a molecular cage and are directed to specific sites in the body via a targeting molecule. Rhenium (Re) is a useful radioactive source that can effectively kill surrounding cells with the energy it emits. It is important for the radioactive source to be secured in the molecular cage so that it will not irradiate unwanted parts of the body. A radiopharmaceutical that will more effectively irradiate the tumor may require fewer testaments, less overall discomfort, and will hopefully result in a lower cost for patients. The focus of this study was to design the cage that would effectively hold Re. Once Re was contained in the cage it was reacted with phosphine to increase its stability. Characterization methods were employed to insure that the structure had formed, but further characterization is needed. If determined stable, radioactive Re will be tested for stability in rat serum.
    URI
    http://hdl.handle.net/10355/643
    Part of
    2004 Undergraduate Research and Creative Achievements Forum (MU)
    Collections
    • 2004 Undergraduate Research and Creative Achievements Forum (MU)

    Send Feedback
    hosted by University of Missouri Library Systems
     

     


    Send Feedback
    hosted by University of Missouri Library Systems